Product launched in India is exceeding sales expectations and is slated for introduction into 30 other countries through a distribution partnership with Cosmofix & San Pellegrino. Added Dr....
In a shocking revelation, it has come to light that Minoxidil Tab. Hyundai, the company's hypertension treatment which is more famous for its off-label use as a hair loss treatment, has inadvertently been labeled as Tamirin ER Tab., a dementia treatment, and given to dementia patients.
Enforcement Report - Week of February 1, 2023
Vir Health and Numan have breached Britain’s drug advertising rules with claims the companies made in a recent TV ad for hair-loss drug Regaine, which contains minoxidil and is called Rogaine in the U.S.
JUPITER, FL / ACCESSWIRE / August 16, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced financial results for the second quarter ended June 30, 2022, and provided an overview of recent operational highlights.
JUPITER, FL / ACCESSWIRE / June 28, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced it has signed an agreement with India-based companies Cosmofix Technology Pvt Ltd and Sanpellegrino Cosmetics Pvt Ltd for the manufacture, sale, and distribution of three proprietary products related to its recent acquisition of Ascent Clinical Research. Jupiter has received an upfront payment and is entitled to royalties of between 10-12% on revenues for the three products with guaranteed annual minimum royalty payments for the duration of the agreement in 31 countries in Asia and the Middle East including India, the Philippines, Malaysia, Kuwait, Morocco, and Saudi Arabia.
JUPITER, FL / ACCESSWIRE / June 23, 2022 / Jupiter Wellness (NASDAQ:JUPW) and Taisho Pharmaceutical Co. Ltd (TYO:4581) today announced that Taisho Pharmaceutical has entered into a license agreement for Jupiter Wellness's minoxidil booster for the Japanese market.
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, has launched two new prescription offerings -- Topical Finasteride & Minoxidil Spray and Oral Spironolactone -- to provide women with more effective solutions to address hair loss, which 1 in 3 women -- roughly 30 million women in the US alone -- experience at some time in their lives.
Enforcement Report - Week of July 8, 2020